Systemic mastocytosis (Q39209): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1144812971
@@ Property / Canonical URI: https://id.who.int/icd/entity/1144812971 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:2A21.0
@@ Property / CURIE: CID11:2A21.0 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-2A21.0
@@ Property / Canary Token: dki-india-2A21.0 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+C96.2
@@ Property / Linked ICD 10: C96.2 / rank @@
+Normal rank

Latest revision as of 04:33, 13 August 2026

Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM).

Language	Label	Description	Also known as
default for all languages	2A21.0
English	Systemic mastocytosis	Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM).